Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BioInvent International AB
BINVCurrent price
50.8 SEK
+0.85 SEK (+1.70%)
Last closed
49.95 SEK
Company
www.bioinvent.com
ISIN
SE0015244520
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
3 234 175 470 SEK
Yield for 12 month
+238.22 %
1Y
3Y
5Y
10Y
15Y
BINV
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. Its drug candidates are BI-1808 is in phase 2 clinical trial and BI-1910 in phase 1 clinical trial for solid tumors targeting Tumor necrosis factor receptor-2 (TNFR2); BI-1206/rituximab in phase 2 clinical trial for the treatment of non-Hodgkin's lymphoma; BI-1206/pembrolizumab and BI-1607/trastuzumab in phase 1 clinical trial to treat solid tumors targeting FCYRIIB; and BT-001 in phase 1 clinical trial for the treatment of solid tumors targeting Cytotoxic T lymphocyte-associated protein-4. The company has a partnership and collaboration with Transgene to develop BT-001 oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck to evaluate BI-1206, BI-1808, and BT-001 in combination with Keytruda; and licensing agreement with CASI pharmaceuticals for BI-1206. The company was incorporated in 1996 and is based in Lund, Sweden. Address: The Gamma Building, Lund, Sweden, 223 70
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
794.06 SEKP/E ratio
–Dividend Yield
–Current Year
+72 192 965 SEK
Last Year
+329 466 454 SEK
Current Quarter
+12 894 743 SEK
Last Quarter
+4 658 226 SEK
Current Year
+72 192 965 SEK
Last Year
+329 466 454 SEK
Current Quarter
+12 894 743 SEK
Last Quarter
+4 658 226 SEK
Key Figures BINV
1 year
3 years
5 years
10 years
EBITDA
-449 796 481 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-22.21 %
PEG Ratio
–
Return On Equity TTM
-34.01 %
Wall Street Target Price
794.06 SEK
Revenue TTM
39 031 743 SEK
Book Value
15.4 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-52.4 %
Dividend Yield
–
Gross Profit TTM
329 466 458 SEK
Earnings per share
-6.28 SEK
Diluted Eps TTM
-6.28 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BINV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BINV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
14.12.2020
Dividend Date
–
Stock Valuation BINV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
58.7093
Price Sales TTM
84.9891
Enterprise Value EBITDA
-20.5879
Price Book MRQ
3.1915
Financials BINV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BINV
For 52 weeks
14.59 SEK
50.51 SEK
50 Day MA
44.43 SEK
Shares Short Prior Month
–
200 Day MA
32.26 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart